Cite
HARVARD Citation
Urup, T. et al. (n.d.). Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients. Molecular oncology. 10 (8), pp. 1160-1168. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Urup, T. et al. (n.d.). Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients. Molecular oncology. 10 (8), pp. 1160-1168. [Online].